Pubblicazioni

A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer

2017 - JOURNAL OF CELLULAR PHYSIOLOGY

Gamucci, Teresa; Mentuccia, Lucia; Natoli, Clara; Sperduti, Isabella; Cassano, Alessandra; Michelotti, Andrea; Di Lauro, Luigi; Sergi, Domenico; Fabi, Alessandra; Sarobba, Maria G.; Marchetti, Paolo; Barba, Maddalena; Magnolfi, Emanuela; Maugeri SaccÃ , Marcello; Rossi, Ernesto; Sini, Valentina; Grassadonia, Antonino; Pellegrini, Domenica; Astone, Antonino; NisticÃ², Cecilia; Angelini, Franco; Vaccaro, Angela; Pellegrino, Arianna; De Angelis, Claudia; Palleschi, Michela; Moscetti, Luca; Bertolini, Ilaria; Buglioni, Simonetta; Giordano, Antonio; Pizzuti, Laura; Vici, Patrizia

Adjuvant chemoradiotherapy in gastric cancer. a pooled analysis of the AIRO Gastrointestinal Group experience

2015 - TUMORI

Mattiucci, Gian Carlo; Valentini, Chiara; D'Agostino, Giuseppe Roberto; Augurio, Antonietta; Capirci, Carlo; De Paoli, Antonino; Genovesi, Domenico; Huscher, Alessandra; Iannone, Tiziana; Pani, Giuseppe; Rosetto, Maria Elena; Sciacero, Piera; Manfrida, Stefania; Corazzi, Francesca; Fusco, Vincenzo; Luppattelli, Marco; Mangiacotti, Maria Grazia; Melano, Antonella; Murino, Paola; Niespolo, Rita; Osti, Mattia Falchetto; Picardi, Vincenzo; Morganti, Alessio Giuseppe; Valentini, Vincenzo

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

2015 - NEW ENGLAND JOURNAL OF MEDICINE

Burger, Ja; Tedeschi, A; Barr, Pm; Robak, T; Owen, C; Ghia, P; Bairey, O; Hillmen, P; Bartlett, Nl; Li, J; Simpson, D; Grosicki, S; Devereux, S; Mccarthy, H; Coutre, S; Quach, H; Gaidano, G; Maslyak, Z; Stevens, Da; Janssens, A; Offner, F; Mayer, J; O'Dwyer, M; Hellmann, A; Schuh, A; Siddiqi, T; Polliack, A; Tam, Cs; Keating, M; Kipps, Tj; Jen, J; Jindra, P; SimkoviÄ, M; Braester, A; Ruchlemer, R; Foa, Roberto; Semenzato, G; Hawkins, T; Atanasio, Cm; Demirkan, F; Kaynar, L; Pylypenko, H; Fox, C; Thirman, M; Campbell, P; Coughlin, P; Harrup, R; Kuss, B; Turner, P; Wu, Kl; Larratt, L; Fineman, R; Marasca, R; Zinzani, Pl; Corbett, G; Abrisqueta, P; Delgado, J; GonzÃ¡lez Barca, E; de Oteyza, Jp; Arsland, O; Kaplan, P; Oliynyk, H; Hamblin, M; Atkins, J; Barrientos, J; Gasic, S; Hou, Jz; Kingsley, E; Shadman, M; Badoux, X; Gill, D; Opat, S; Bron, D; Van Den Neste, E; Jing, H; Zhu, J; Vandenberghe, E; Tadmor, T; Cortelezzi, A; Ganly, P; Weinkove, R; Pluta, A; Pristupa, A; GarcÃa Marco, Ja; Vural, F; YaÄci, M; Kasych, M; Duncombe, A; Fegan, C; Quackenbush, R; Tirumali, N.

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4). A double-blind, multicentre, phase 3, randomised, placebo-controlled trial

2015 - THE LANCET ONCOLOGY

Saad, Fred; Fizazi, Karim; Jinga, Viorel; Efstathiou, Eleni; Fong, Peter C; Hart, Lowell L; Jones, Robert; Mcdermott, Raymond; Wirth, Manfred; Suzuki, Kazuhiro; Maclean, David B; Wang, Ling; Akaza, Hideyuki; Nelson, Joel; Scher, Howard I; Dreicer, Robert; Webb, Iain J; de Wit, Ronald; Collaborators, ; Tubaro, Andrea